Catherine, Princess of Wales opens up about ‘really difficult' cancer recovery
During a visit to a wellbeing garden at Colchester Hospital, in Essex, England on Wednesday, the princess told patients: 'You put on a sort of brave face, stoicism through treatment, treatment's done – then it's like 'I can crack on, get back to normal.'
'But actually the phase afterwards is really difficult, you're not necessarily under the clinical team any longer, but you're not able to function normally at home as you perhaps once used to,' she added.
Kate visited the hospital garden in the southeast of England to 'celebrate the incredible healing power of nature,' according to Kensington Palace.
During the visit, the princess also met with patients and staff at the hospital's Cancer Wellbeing Centre 'to understand how gardens in healthcare settings play a crucial role in promoting good health outcomes, preventing poor health and supporting increased recovery time,' the palace said.
Kate, 43, has underlined the importance of nature in her health journey over the last year.
'Over the past year, nature has been my sanctuary,' she said in a video posted on X to mark Mental Health Awareness Week in May.
Kate revealed her cancer diagnosis and that she had started chemotherapy last March. As she underwent treatment, she stepped back from public life and only made a few rare appearances last summer. In September, she announced she had completed chemotherapy and was 'doing what I can to stay cancer free.'
Although she has taken on more appearances this year, the popular royal is understood to be working to find the right balance as she returns to public duties after treatment.
Before dropping out of Ascot at short notice, Kate had attended a number of engagements in recent weeks, including two major events in the royal calendar, the Trooping the Colour parade in London and the Order of the Garter service in Windsor.
She resumed in-person duties last week when she and Prince William invited Melinda French Gates for a meeting at Windsor Castle. They were understood to have discussed their philanthropic work, according to Britain's PA Media news agency.
Kate's visit to Colchester Hospital on Wednesday coincided with the hospital accepting a donation of 50 'Catherine's Rose' plants, a specially-bred rose named in her honor by the Royal Horticultural Society. She planted some of these roses, which, when sold commercially, will have their proceeds donated to The Royal Marsden Cancer Charity.
Kate has become deeply involved in the charity since her diagnosis. In January, Kensington Palace announced that she had been named the joint patron of The Royal Marsden NHS Foundation Trust, the specialist cancer center in Chelsea, west London, where she was treated.
Funds from the sale of these roses will be used to help the charity establish a specialist program helping cancer patients live well with the disease, and after their treatment has been completed.
CNN's Lauren Said-Moorhouse and Olivia Kemp contributed reporting.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
UK Government to introduce new digital system for NHS
The UK Government has announced a strategy to expedite technology access across the National Health Service (NHS) with a new digital system. This initiative aims to reduce bureaucratic challenges and enhance life science through a streamlined process. The forthcoming 'innovator passport', set to launch over the next two years, will enable technologies assessed by one NHS organisation to be implemented by others. This is a focal point of the government's Plan for Change and its ten-year vision for health, which seeks to shape an NHS that is ready for the future. Complex procedures and slow approval times have previously deterred businesses from engaging with the NHS. The new system is set to eliminate these barriers, enabling organisations to collaborate with the NHS. A 'one-stop shop' thorough check will allow businesses to promptly commence operations across the nation. NHS patients will therefore benefit from quicker access to more effective treatments and support. The 'innovator passport' will eliminate the need for multiple compliance assessments, lessening redundancy within the health service. MedTech Compass, a digital platform developed by the Department of Health and Social Care (DHSC), will facilitate the delivery of the passport. Health and Social Care Secretary of State Wes Streeting said: 'These innovator passports will save time and reduce duplication, meaning our life sciences sector, a central part of our 10-Year Health Plan, can work hand-in-hand with the health service and make Britain a powerhouse for medical technology.' This platform will also support the Life Sciences Sector Plan, part of the industrial strategy designed to improve Britain's life sciences sector. Once a healthcare tool is evaluated by one NHS organisation, other organisations will no longer require repeated assessments, allowing local systems to conserve resources previously spent on duplicative bureaucratic processes. "UK Government to introduce new digital system for NHS" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

Yahoo
10 minutes ago
- Yahoo
Summit Therapeutics stock rises after report of potential $15B AstraZeneca deal
-- Summit Therapeutics (NASDAQ:SMMT) stock rose 5% on Thursday while AstraZeneca (NASDAQ:AZN) shares fell 2% following a Bloomberg report that the companies are in discussions for a potential $15 billion partnership deal. According to the report, AstraZeneca is considering a licensing agreement for Summit's ivonescimab lung cancer treatment. The deal structure could include a multi-billion dollar upfront payment followed by milestone payments that could bring the total value to approximately $15 billion over time. Summit has also reportedly been in talks with other major pharmaceutical companies about the experimental cancer drug, suggesting competitive interest in the treatment. The negotiations are still ongoing, and terms are being finalized, though the discussions could still fall apart or Summit might choose a different partner. Related articles Summit Therapeutics stock rises after report of potential $15B AstraZeneca deal What could a shift in Intel's foundry strategy bring? Growth funds favor Makemytrip and SK Hynix: BofA Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
Eagles Super Bowl Champion, 38, Diagnosed With Cancer
Eagles Super Bowl Champion, 38, Diagnosed With Cancer originally appeared on Athlon Sports. The Philadelphia Eagles capped off the 2024 NFL season with the franchise's second Lombardi Trophy, defeating the Kansas City Chiefs in Super Bowl LIX. Advertisement The Eagles won their first Super Bowl back in the 2017 NFL season, knocking off Tom Brady and the New England Patriots. During that run, former defensive end Bryan Braman may have had the best moment of his NFL career, blocking an Atlanta Falcons punt in the Divisional Round. Now, over seven years removed from his Super Bowl win, Braman has been diagnosed with a "very rare form of cancer" at only 38 years old. A GoFundMe fundraiser called "Donate to Bryan Braman's Healing Journey" was started in light of the diagnosis, with a goal of $25,000. At the time of this article, donations exceeded $20,000. Even his former Houston Texans teammate, J.J. Watt, pitched in $10,000. Former Philadelphia Eagles free safety Malcolm Jenkins and defensive end Bryan BramanBill Streicher-Imagn Images According to his GoFundMe, Braman is back home with his family after undergoing CAR-T cell therapy in Seattle for a rare and aggressive form of cancer. While the treatment initially showed promise, the cancer has since returned and is spreading rapidly. But due to his compromised immune system and previous treatments, his chemotherapy options are now limited. Advertisement Despite this, Braman remains hopeful and is exploring potential options, including trial treatments. Recent donations have helped him afford dietary needs and treatment costs. "I would like to take this moment to thank ALL of the donors that have come forward and donated, no matter the size," the GoFundMe read. "Every dollar came in at the exact time, to cover the next expense, as they came along." Braman started his career with the Texans after going undrafted in 2011. He spent three seasons there before joining the Eagles for another three in 2014. After his first stint in Philadelphia, Braman joined the New Orleans Saints before being placed on injured reserve, getting released one week later. Advertisement Just before the playoffs began during the 2017 season, Braman re-joined the Eagles, and the rest is history. Related: Patrick Mahomes Makes Off-Field Move With Chiefs Star This story was originally reported by Athlon Sports on Jul 3, 2025, where it first appeared.